STOCK TITAN

Nu-Med Plus (NUMD) Stock News

NUMD OTC

Welcome to our dedicated page for Nu-Med Plus news (Ticker: NUMD), a resource for investors and traders seeking the latest updates and insights on Nu-Med Plus stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nu-Med Plus's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nu-Med Plus's position in the market.

Rhea-AI Summary

Nu-Med Plus (OTCQB: NUMD) announced the completed acquisition of Avid Gold and its wholly owned subsidiary Maritimes Gold, a Canadian gold exploration and development company. Nu-Med and its subsidiaries also entered into a Mineral Property Purchase Agreement with MegumaGold and its subsidiaries to acquire six gold properties in Nova Scotia, New Brunswick, and Newfoundland and Labrador.

The Properties cover more than 30,900 acres of mineral claims in Atlantic Canada, with four located in the Meguma Terrane, a major Canadian gold-producing region. The company will be led by an experienced board, with former CEO William Hayde becoming Chairman, Keith Merrell continuing as CFO and director, and geologist Fred Tejada joining as director and Sr. Vice President & Chief Geologist to lead gold exploration activities. Closing of the Mineral Property Purchase Agreement remains subject to MegumaGold shareholder approval and other customary conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.14%
Tags

FAQ

What is the current stock price of Nu-Med Plus (NUMD)?

The current stock price of Nu-Med Plus (NUMD) is $0.0184 as of July 24, 2026.

What is the market cap of Nu-Med Plus (NUMD)?

The market cap of Nu-Med Plus (NUMD) is approximately 1.5M.